Rolando Rodriguez, MD
Endocrinology · Boca Raton, FLNPI 1245344746
Payments from drug & device makers
Across 440 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Sanofi-aventis U.S. LLC$945
- Novo Nordisk$897
- AbbVie$732
- Amgen$592
- Boehringer Ingelheim$471
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 78 | $1,306 |
| Sanofi-aventis U.S. LLC | 45 | $945 |
| Novo Nordisk | 65 | $897 |
| AbbVie | 41 | $732 |
| Amgen(2 entities) | 31 | $592 |
| Boehringer Ingelheim | 27 | $471 |
| Bayer | 17 | $422 |
| Corcept Therapeutics | 21 | $404 |
| Amneal Pharmaceuticals LLC | 16 | $256 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $203 |
| Radius Health, Inc. | 9 | $150 |
| AstraZeneca(2 entities) | 8 | $149 |
| Xeris Pharmaceuticals, Inc. | 7 | $137 |
| Dexcom, Inc. | 5 | $118 |
| Lifescan, Inc. | 6 | $113 |
| Valeritas, Inc. | 5 | $110 |
| Merck | 6 | $98 |
| Mannkind Corporation | 5 | $91 |
| BD | 4 | $85 |
| Pfizer | 3 | $74 |
| Cvrx, Inc. | 1 | $74 |
| Recordati_rare_diseases_inc. | 4 | $74 |
| Shire North American Group Inc | 3 | $64 |
| IBSA Pharma Inc. | 3 | $63 |
| Abbott | 3 | $57 |
| Novartis | 3 | $54 |
| Johnson & Johnson | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $21 |
| Alvogen Inc | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Vistapharm, Inc. | 1 | $17 |
| Biomerieux Inc | 1 | $15 |
| Medtronic | 1 | $14 |
How this compares
Too few endocrinology providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology in Boca Raton
- Bryan VinikBoca Raton$13K
- Renee FreedmanBoca Raton$10K
- Kathryn JonesBoca Raton$142
- Rodolfo Perez LopezHialeah$10.6M
- Vivian RoseCoral Springs$214K
- Carlos ZapataTallahassee$5K
- Michael FiliMiami$4K
- Mohammad BaigTampa$2K
- Myat MyintHudson$182
- Alan BalsamDeerfield Beach$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.